Mirum Pharmaceuticals (MIRM) Assets Average (2019 - 2026)

Mirum Pharmaceuticals has reported Assets Average for 8 years, with the latest figure at $866.9 million in Q1 2026.

• For the quarter ending Q1 2026, Assets Average rose 27.39% year-over-year to $866.9 million; the trailing twelve-month figure through Mar 2026 stood at $866.9 million (up 27.39% YoY), and the FY2025 full-year result was $756.8 million, up 14.89% from the prior year.
• Assets Average for Q1 2026 stood at $866.9 million, up from $814.0 million in the prior quarter.
• The five-year high for Assets Average was $866.9 million in Q1 2026, with the low at $286.4 million in Q1 2022.
• Average Assets Average over 5 years is $568.0 million, with a median of $649.3 million recorded in 2024.
• Peak annual rise in Assets Average reached 89.18% in 2024, while the deepest fall reached 3.19% in 2024.
• Tracing MIRM's Assets Average over 5 years: stood at $358.6 million in 2022, then jumped by 80.87% to $648.6 million in 2023, then advanced by 3.19% to $669.3 million in 2024, then advanced by 21.61% to $814.0 million in 2025, then grew by 6.5% to $866.9 million in 2026.
• The last three Assets Average figures came in at $866.9 million (Q1 2026), $814.0 million (Q4 2025), and $755.5 million (Q3 2025), per Business Quant data.

Peer Comparison